H. Pinnock (Edinburgh (Edinburgh), United Kingdom), A. Aliverti (Milan, Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Initial observed improvement in medication adherence maintained during the COVID-19 pandemic in asthma and COPD
L. Kaye (San Francisco, United States of America), J. Nagano (San Francisco, United States of America), V. Vuong (San Francisco, United States of America), M. Barrett (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)
|    |
Early supported discharge of COVID-19 patients with home oxygen therapy
R. Harkness (Manchester, United Kingdom), A. Rezgui (Manchester, United Kingdom), R. Towns (Manchester, United Kingdom), R. Lessons (Manchester, United Kingdom), A. Lindley (Manchester, United Kingdom), H. Law (Manchester, United Kingdom), D. Thomson (Manchester, United Kingdom)
| |
Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease
K. Schnoor (Leiden, Netherlands), A. Versluis (Leiden, Netherlands), R. Bakema (Den Bosch, Netherlands), S. Van Luenen (Leiden, Netherlands), M. Kooij (Amsterdam, Netherlands), M. Van Den Heuvel (Amsterdam, Netherlands), P. Hoogland (Den Bosch, Netherlands), M. Teichert (Leiden, Netherlands), J. Van Boven (Groningen, Netherlands), N. Chavannes (Leiden, Netherlands), J. Aardoom (Leiden, Netherlands)
| |
Physiological measurements with wearables during urban walks for telemonitoring of patients with COPD
J. Buekers (Barcelona, Spain), A. Arbillaga-Etxarri (Donostia-San Sebastián, Spain), E. Gimeno-Santos (Barcelona, Spain), G. Chevance (Barcelona, Spain), J. Aerts (Leuven, Belgium), J. Garcia-Aymerich (Barcelona, Spain)
| |
Vironix: remote screening, detection, and triage of viral respiratory illness via cloud-enabled, machine-learned APIs.
S. Swaminathan (Austin, United States of America), B. Toro (Austin, United States of America), N. Wysham (Vancouver, United States of America), N. Mark (Seattle, United States of America), S. Ramanathan (Palo Alto, United States of America), J. Morrill (Oxford, United Kingdom), V. Konda (Champaign, United States of America), S. Iyer (Charlotte Latin School, United States of America), C. Landon (Ventura, United States of America)
| |
Engagement with an asthma app to monitor medication adherence and its association with patients’ characteristics
C. Oliveira Jácome (Porto, Portugal), R. Almeida (Porto, Portugal), A. Pereira (Porto, Portugal), R. Amaral (Porto, Portugal), S. Mendes (Porto, Portugal), M. Alves-Correia (Porto, Portugal), C. Vidal (Santiago, Spain), S. López Freire (Santiago, Spain), P. Méndez Brea (Santiago, Spain), L. Araujo (Porto, Portugal), M. Couto (Porto, Portugal), D. Antolín-Amérigo (ARADYAL Madrid, Spain), B. De La Hoz Caballer (ARADYAL Madrid, Spain), A. Barra Castro (ARADYAL Madrid, Spain), D. Gonzalez-De-Olano (ARADYAL Madrid, Spain), A. Todo Bom (Coimbra, Portugal), J. Azevedo (Leiria, Portugal), P. Leiria Pinto (Lisboa, Portugal), N. Pinto (Lisboa, Portugal), A. Castro Neves (Lisboa, Portugal), A. Palhinha (Lisboa, Portugal), F. Todo Bom (Loures, Portugal), A. Costa (Guimarães, Portugal), C. Chaves Loureiro (Coimbra, Portugal), L. Maia Santos (Figueira da Foz, Portugal), A. Arrobas (Coimbra, Portugal), M. Valério (Coimbra, Portugal), J. Cardoso (Lisboa, Portugal), M. Emiliano (Lisboa, Portugal), R. Gerardo (Lisboa, Portugal), J. Cidrais Rodrigues (Matosinhos, Portugal), G. Oliveira (Matosinhos, Portugal), J. Carvalho (Matosinhos, Portugal), A. Mendes (Lisboa, Portugal), C. Lozoya (Castelo Branco, Portugal), N. Santos (Portimão, Portugal), F. Menezes (Almada, Portugal), R. Gomes (Almada, Portugal), R. Câmara (Funchal, Portugal), R. Rodrigues Alves (Ponta Delgada, Portugal), A. Moreira (Ponta Delgada, Portugal), D. Bordalo (Vila Nova de Famalicão, Portugal), C. Alves (Barreiro, Portugal), D. Coelho-Barreiro (Barreiro, Portugal), J. Ferreira (Vila Nova de Gaia, Portugal), C. Lopes (Porto, Portugal), D. Silva (Porto, Portugal), M. Vasconcelos (Porto, Portugal), M. Teixeira (Porto, Portugal), M. Ferreira-Magalhães (Porto, Portugal), L. Taborda-Barata (Covilhã, Portugal), M. Cálix (Viseu, Portugal), A. Alves (Vila Nova de Gaia, Portugal), J. Almeida Fonseca (Porto, Portugal)
| |
Assessment of patient engagement and adherence with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler digital companion in asthma: interim analysis from Germany
H. Woehrle (Ulm, Germany), P. Mastoridis (East Hanover, New Jersey, United States of America), D. Stempel (San Francisco, CA, United States of America), L. Kaye (San Francisco, CA, United States of America), C. Doan (San Francisco, CA, United States of America), K. Mezzi (Basel, Switzerland)
| |
Remote monitoring of patients with COPD using a tablet system: proof of concept.
M. Frerichs (Gothenburg, Sweden), K. Andelid (Gothenburg, Sweden), A. Nordenson (Gothenburg, Sweden), A. Andersson (Gothenburg, Sweden), M. Crona (Gothenburg, Sweden), D. Dohmen (Amsterdam, Netherlands), A. Ullman (Gothenburg, Sweden), L. Vanfleteren (Gothenburg, Sweden)
| |
Roll-out of video-supported treatment in Moldova to promote people-centered model of care
C. Celan (Chisinau, Republic of Moldova), S. Bivol (Chisinau, Republic of Moldova), V. Vilc (Chisinau, Republic of Moldova), S. Alexandru (Chisinau, Republic of Moldova), L. Severin (Chisinau, Republic of Moldova)
| |
Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
M. Roberts (Cambridge (Cambridgeshire), United Kingdom), K. Kirov (Cambridge (Cambridgeshire), United Kingdom), T. Mclellan (Cambridge (Cambridgeshire), United Kingdom), E. Morgan (Cambridge (Cambridgeshire), United Kingdom), F. Kanavati (Cambridge (Cambridgeshire), United Kingdom), D. Gallagher (Cambridge (Cambridgeshire), United Kingdom), P. Molyneaux (London, United Kingdom), C. Schönlieb (Cambridge (Cambridgeshire), United Kingdom), A. Ruggiero (Cambridge (Cambridgeshire), United Kingdom), M. Thillai (Cambridge (Cambridgeshire), United Kingdom)
| |
Discussion
| |